Contact

Big news: Profil is coming to the US!

We are excited to announce that Profil is officially establishing its first clinical research unit in the US.  By joining forces with Tranquil Clinical Research, we are taking a massive leap forward. Our new site is located in the Houston metropolitan area, one of the most diverse and fastest growing regions in the United States. This merger  is so much more than just expansion. It is a testament to our incredible growth, the deep trust our customers place in us, and our proud position as leaders in the metabolic field. The new research facility complements our existing capabilities by adding further opportunities including access to a broader patient population thereby enabling rapid recruitment and enhanced collaboration with the FDA to facilitate faster approval timelines.

Your benefits

Save time:

Fast regulatory timeline and access to new large and diverse patient population for faster trial execution

Work with experts:

Established high quality processes and sophisticated methodologies

Scientific excellence:

Over 25 years' experience in the metabolic field allows for reliable data and confident decisions.


Our clinical research units

Neuss

Our research unit in Neuss, Germany

Profil’s research unit in Neuss is our established center of excellence for early-phase metabolic trials. Located near Düsseldorf, the research unit offers dedicated infrastructure for complex studies in diabetes and obesity with over 60 beds. 


Houston (1)

Our research unit in Houston, Texas

Profil’s research unit in the Houston metropolitan area is the newest member of the Profil family. Its location provides access to one of the largest healthcare and life-science ecosystems in the United States, with proximity to Houston's medical infrastructure and diverse patient populations.

Press release: Read what the management says about the merger.

Find out more about the new company structure and how the merger will benefit Profil and their customers for future trials.